Abstract
The advantages that it has the PET/CT are: 1. It diminishes mainly positive false lesions. It identifies physiologic accumulate places. 2. It diminishes in smaller grade false negative. Small injuries. Injuries with low grade concentration. Injure on intense activity areas. 3. Precise anatomical localization of accumulate places. 4. Reduction of the acquisition time. (Author)
Garcia O, J R
[1]
- Nuclear Medicine and Molecular Imaging PET/CT, Centro Medico ABC, Mexico D.F. (Mexico)
Citation Formats
Garcia O, J R.
PET and PET/CT in malignant melanoma; PET y PET/CT en melanoma maligno.
Mexico: N. p.,
2007.
Web.
Garcia O, J R.
PET and PET/CT in malignant melanoma; PET y PET/CT en melanoma maligno.
Mexico.
Garcia O, J R.
2007.
"PET and PET/CT in malignant melanoma; PET y PET/CT en melanoma maligno."
Mexico.
@misc{etde_20944819,
title = {PET and PET/CT in malignant melanoma; PET y PET/CT en melanoma maligno}
author = {Garcia O, J R}
abstractNote = {The advantages that it has the PET/CT are: 1. It diminishes mainly positive false lesions. It identifies physiologic accumulate places. 2. It diminishes in smaller grade false negative. Small injuries. Injuries with low grade concentration. Injure on intense activity areas. 3. Precise anatomical localization of accumulate places. 4. Reduction of the acquisition time. (Author)}
place = {Mexico}
year = {2007}
month = {Jul}
}
title = {PET and PET/CT in malignant melanoma; PET y PET/CT en melanoma maligno}
author = {Garcia O, J R}
abstractNote = {The advantages that it has the PET/CT are: 1. It diminishes mainly positive false lesions. It identifies physiologic accumulate places. 2. It diminishes in smaller grade false negative. Small injuries. Injuries with low grade concentration. Injure on intense activity areas. 3. Precise anatomical localization of accumulate places. 4. Reduction of the acquisition time. (Author)}
place = {Mexico}
year = {2007}
month = {Jul}
}